NCT02895581

Brief Summary

Retrospective medical chart review of HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2015

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

September 6, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 9, 2016

Completed
Last Updated

September 9, 2016

Status Verified

September 1, 2016

Enrollment Period

9 years

First QC Date

September 6, 2016

Last Update Submit

September 6, 2016

Conditions

Progressive Multifocal Leukoencephalopathy

Outcome Measures

Primary Outcomes (1)

  • Rankin score

    12 months after diagnosis of leukoencephalopathy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

HIV-infected patients diagnosed with progressive multifocal leukoencephalopathy

You may qualify if:

  • HIV infected patients
  • Diagnosed with progressive multifocal leukoencephalopathy
  • Minimal follow-up of one year OR patient deceased less than one year after diagnosis

You may not qualify if:

  • Loss of follow-up within 12 months after diagnosis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Leukoencephalopathy, Progressive Multifocal

Condition Hierarchy (Ancestors)

Encephalitis, ViralCentral Nervous System Viral DiseasesCentral Nervous System InfectionsInfectionsInfectious EncephalitisVirus DiseasesPolyomavirus InfectionsDNA Virus InfectionsSlow Virus DiseasesEncephalitisBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesLeukoencephalopathiesDemyelinating DiseasesNeuroinflammatory Diseases

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 6, 2016

First Posted

September 9, 2016

Study Start

January 1, 2006

Primary Completion

January 1, 2015

Last Updated

September 9, 2016

Record last verified: 2016-09